Real-time enrollment status for this hereditary angioedema (hae) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:39 AM UTC
| NCT Number | NCT07428499 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Angioedema (HAE) |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 15 sites in the US |
| Sponsor | ADARx Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 16, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07428499 is currently recruiting participants. This clinical trial study for hereditary angioedema (hae) is actively seeking new participants at 15 locations across the United States. The study is sponsored by ADARx Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07428499 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07428499 was last updated 3 weeks ago (June 16, 2026). HelloStudys verifies this status automatically.